FDA — authorised 17 June 2010
- Application: NDA201023
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: JEVTANA KIT
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Jevtana Kit in United States
FDA authorised Jevtana Kit on 17 June 2010
Marketing authorisation
Jevtana Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Jevtana Kit approved in United States?
Yes. FDA authorised it on 17 June 2010.
Who is the marketing authorisation holder for Jevtana Kit in United States?
SANOFI AVENTIS US holds the US marketing authorisation.